What the Affordable Care Act Means for Physicians: A Q&A with Avik Roy
June 30th 2014Avik Roy, Senior Fellow at the Manhattan Institute for Policy Research, Opinion Editor of Forbes, and Editor of The Apothecary blog about healthcare and entitlement reform, breaks down the intricacies of the Affordable Care Act for internists.
Benefits of Azithromycin Outweigh Risks in Elderly Hospitalized with Pneumonia
Among patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.
Genzyme Reattempts Relapsing-remitting Multiple Sclerosis Indication for Alemtuzumab
June 26th 2014European regulators recently approved alemtuzumab to treat active relapsing-remitting multiple sclerosis, but the US Food and Drug Administration denied the drug for that indication last year.
EMR-based Approach to Opioids Offers Peace of Mind to Prescribers
Although many primary care physicians remain uncertain of how to best help patients in pain manage their opioid prescriptions, new research shows a standardized protocol based on electronic medical records can get patients the assistance they need while providing peace of mind to prescribers.
Preventive Implantable Cardioverter-defibrillators Improve Survival in Heart Failure Patients
A retrospective cohort study of Medicare beneficiaries hospitalized for heart failure with a left ventricular ejection fraction between 30-35% found improved 3-year survival rates among those who received a prophylactic implantable cardioverter-defibrillators compared to those with no ICD.
Tackling the Tricky Trio of Pain, Diabetes, and Sleep Dysfunction
June 18th 2014Although clinicians are increasingly forced to face the 3-headed monster of comorbid diabetes, sleep disturbance, and pain, the healthcare community is only beginning to understand how the conditions overlap.
Durability Seen in Clinical Cardiology Guideline Recommendations Based on Multiple Randomized Trials
Cardiology guideline recommendations that are based on multiple randomized studies have the most durability over time, researchers from the University of Pennsylvania have found.